SODIUM 2-(3,4-DICHLOROBENZYL)-5-METHYL-4-OXO-3,4-DIHYDROTHIENO(2,3-D)PYRIMIDINE-6-CARBOXYLATE
UNII XI0J29LT6T
Substance Identification & Data
This profile provides standardized clinical and technical data for Sodium 2-(3,4-dichlorobenzyl)-5-methyl-4-oxo-3,4-dihydrothieno(2,3-d)pyrimidine-6-carboxylate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) XI0J29LT6T.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 917089-11-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C15H9Cl2N2O3S.Na RJIOLXBAHFPELT-UHFFFAOYSA-M Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Sodium 2-(3,4-dichlorobenzyl)-5-methyl-4-oxo-3,4-dihydrothieno(2,3-d)pyrimidine-6-carboxylate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.